HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) - ANVISA Registration 80146502052

Access comprehensive regulatory information for HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80146502052 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Nov 27, 2027.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146502052
2 Related Devices
Registration Details
ANVISA Registration Number: 80146502052
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

80146502052

25351384001201755

56998701000116

Company Information

Ireland
PT: IRLANDA

Dates and Status

Nov 27, 2017

27/11/2027

09/18/2025 19:00:01

Registration Details

80146502052

25351384001201755

56998701000116

Company Information

Dates and Status

Nov 27, 2017

27/11/2027

09/18/2025 19:00:01